TOPLINE: A single dose of EDIT-101, a CRISPR-associated protein 9 (Cas9)-based gene-editing therapy, appears safe and improves vision and sensitivity to light in patients with retinal […]

TOPLINE: Pediatric patients with atopic dermatitis (AD) who are prescribed dupilumab may be at a reduced risk for atopic march progression, defined as the development of […]

TOPLINE: Smoking, higher body mass index (BMI), and previous exposure to biologics were linked to poorer responses to biologics among patients with psoriasis, in a meta-analysis. […]

TOPLINE: Nearly one-fifth of people in Sweden during 2015-2019 had diabetic retinopathy (DR) at the time of type 2 diabetes (T2D) diagnosis, indicating longstanding hyperglycaemia and […]

TOPLINE: A probiotic with good rationale from animal and human studies known as L reuteri (Limosilactobacillus reuteri 6475) failed in a placebo-controlled clinical trial to prevent […]

TOPLINE: In adults with type 1 diabetes (T1D), both management- and emotion-focused virtual group programs can lead to a clinically meaningful reduction in diabetes distress (DD) […]

TOPLINE: In patients with irritable bowel syndrome (IBS), a dietitian-guided 12-week strict low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet (LFD) improves quality of life […]

TOPLINE: ChatGPT4 outperformed gastroenterology practitioners and showed better concordance with the 2020 US Multi-Society Task Force on Colorectal Cancer (USMSTF) guidelines in determining rescreening and surveillance […]

TOPLINE: The artificial intelligence (AI) chatbot ChatGPT can significantly improve the readability of online cancer-related patient information while maintaining the content’s quality, a recent study found. […]